Consensus Guidelines for the Prevention and Treatment of Catheter-Related Infections and Peritonitis in Pediatric Patients Receiving Peritoneal Dialysis: 2012 Update

Auron A. , Simon S. , Andrews W. , Jones L. , Johnson S. , Musharaf G. Prevention of peritonitis in children receiving peritoneal dialysis. Pediatr Nephrol 2007; 22: 578–85.

The EMMES Corporation. North American Pediatric Renal Trials and Collaborative Studies: NAPRTCS 2008 Annual Report. Renal Transplantation, Dialysis, Chronic Renal Insufficiency. Rockville, MD: The EMMES Corporation; 2008. [Available online at: https://web.emmes.com/study/ped/annlrept/Annual%20Report%20-2008.pdf; accessed April 2012]

Warady B.A. , Schaefer F. , Holloway M. , Alexander S. , Kandert M. , Piraino B. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int 2000; 20: 610–24.

Warady B.A. , Feneberg R. , Verrina E. , Flynn J.T. , Müller-Wiefel D.E. , Besbas N. Peritonitis in children who receive long-term dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol 2007; 18: 2172–9.

Schaefer F. , Feneberg R. , Aksu N. , Donmez O. , Sadikoglu B. , Alexander S.R. Worldwide variation of dialysis-associated peritonitis in children. Kidney Int 2007; 72: 1374–9.

KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(Suppl 3): S1–155.

Li P.K. , Szeto C.C. , Piraino B. , Bernardini J. , Figueiredo A.E. , Gupta A. Peritoneal dialysis–related infections recommendations: 2010 update. Perit Dial Int 2010; 30: 393–423.

Bernardini J. , Price V. , Figueiredo A. on behalf of the International Society for Peritoneal Dialysis (ISPD) Nursing Liaison Committee. Peritoneal dialysis patient training, 2006. Perit Dial Int 2006; 26: 625–32.

Bernardini J. , Price V. , Figueiredo A. , Riemann A. , Leung D. International survey of peritoneal dialysis training programs. Perit Dial Int 2006; 26: 658–63.

Holloway M. , Mujais S. , Kandert M. , Warady B.A. Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates. Perit Dial Int 2001; 21: 401–4.

Gunasekara W.D. , Ng K.H. , Chan Y.H. , Aragon E. , Foong P.P. , Lau Y.W. Specialist pediatric dialysis nursing improves outcomes in children on chronic peritoneal dialysis. Pediatr Nephrol 2010; 25: 2141–7.

Bordin G. , Casati M. , Sicolo N. , Zuccherato N. , Eduati V. Patient education in peritoneal dialysis: an observational study in Italy. J Ren Care 2007; 33: 165–71.

Hall G. , Bogan A. , Dreis S. , Duffy A. , Greene S. , Kelley K. New directions in peritoneal dialysis patient training. Nephrol Nurs J 2004; 31: 149–54, 159–63.

Coles G. , Uttley L. Recommendations of the International Society for Peritoneal Dialysis for training requirements of nephrology trainees and nurses. Perit Dial Int 1994; 14: 115–16.

Chow K.M. , Szeto C.C. , Law M.C. , Fun Fung J.S. , Kam–Tao Li P. Influence of peritoneal dialysis training nurses’ experience on peritonitis rates. Clin J Am Soc Nephrol 2007; 2: 647–52.

Jones L. , Aldridge M. Organization and management of a pediatric dialysis program. In: Warady B.A. , Schaefer F.S. , Alexander S.R. , eds. Pediatric Dialysis. New York, NY: Springer; 2011.

Winterbottom A. , Conner M. , Mooney A. , Bekker H.L. Evaluating the quality of patient leaflets about renal replacement therapy across UK renal units. Nephrol Dial Transplant 2007; 22: 2291–6.

Bender F.H. , Bernardini J. , Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl 2006; (103): S44–54.

Miller T.E. , Findon G. Touch contamination of connection devices in peritoneal dialysis—a quantitative microbiologic analysis. Perit Dial Int 1997; 17: 560–7.

Firanek C. , Guest S. Hand hygiene in peritoneal dialysis. Perit Dial Int 2011; 31: 399–408.

Pittet D. , Allegranzi B. , Boyce J. on behalf of the World Health Organization World Alliance for Patient Safety First Global Patient Safety Challenge Core Group of Experts. The World Health Organization Guidelines on hand hygiene in health care and their consensus recommendations. Infect Control Hosp Epidemiol 2009; 30: 611–22.

Watson A.R. , Gartland C. on behalf of the European Paediatric Peritoneal Dialysis Working Group. Guidelines by an ad hoc European committee for elective chronic peritoneal dialysis in pediatric patients. Perit Dial Int 2001; 21: 240–4.

Chua A.N. , Warady B.A. Adherence of pediatric patients to automated peritoneal dialysis. Pediatr Nephrol 2011; 26: 789–93.

Schiller B. , Alcaraz M. , Hadley K. , Moran J. Peritonitis and zoonosis: your best friend sometimes isn't! Perit Dial Int 2011; 31: 127–30.

Chadha V. , Warady B.A. Capnocytophaga canimorsus peritonitis in a pediatric peritoneal dialysis patient. Pediatr Nephrol 1999; 13: 646–8.

Russo R. , Manili L. , Tiraboschi G. , Amar K. , De Luca M. , Alberghini E. Patient re-training in peritoneal dialysis: why and when is it needed? Kidney Int Suppl 2006; (103): S127–32.

Bakkaloglu S.A. Prevention of peritonitis in children: emerging concepts. Perit Dial Int 2009; 29(Suppl 2): S186–9.

Golper T.A. , Brier M.E. , Bunke M. , Schreiber M.J. , Bartlett D.K. , Hamilton R.W. Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis 1996; 28: 428–36.

Eklund B. , Honkanen E. , Kyllönen L. , Salmela K. , Kala A.R. Peritoneal dialysis access: prospective randomized comparison of single-cuff and double-cuff straight Tenckhoff catheters. Nephrol Dial Transplant 1997; 12: 2664–6.

Lo W.K. , Lui S.L. , Li F.K. , Choy B.Y. , Lam M.F. , Tse K.C. A prospective randomised study on three different peritoneal dialysis catheters. Perit Dial Int 2003; 23(Suppl 2): S127–31.

Strippoli G.F. , Tong A. , Johnson D. , Schena F.P. , Craig J.C. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. J Am Soc Nephrol 2004; 15: 2735–46.

Lane J.C. , Warady B.A. , Feneberg R. , Majkowski N.L. , Watson A.R. , Fischbach M. Relapsing peritonitis in children who undergo chronic peritoneal dialysis: a prospective study of the International Pediatric Peritonitis Registry. Clin J Am Soc Nephrol 2010; 5: 1041–6.

Zurowska A. , Feneberg R. , Warady B.A. , Zimmering M. , Monteverde M. , Testa S. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis 2008; 51: 455–62.

Furth S.L. , Donaldson L.A. , Sullivan E.K. , Watkins S.L. on behalf of the North American Pediatric Renal Transplant Cooperative Study. Peritoneal dialysis catheter infections and peritonitis in children: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 2000; 15: 179–82.

Neu A.M. , Ho P.L. , McDonald R.A. , Warady B.A. Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report. Pediatr Nephrol 2002; 17: 656–63.

Chadha V. , Jones L.L. , Ramirez Z.D. , Warady B.A. Chest wall placement of peritoneal dialysis catheters in infants with a colostomy. Adv Perit Dial 2000; 16: 318–20.

Warchol S. , Ziolkowska H. , Roszkowska-Blaim M. Exit-site infection in children on peritoneal dialysis: comparison of two types of peritoneal catheters. Perit Dial Int 2003; 23: 169–73.

Rinaldi S. , Sera F. , Verrina E. , Edefonti A. , Gianoglio B. , Perfumo F. Chronic peritoneal dialysis catheters in children: a fifteen-year experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis. Perit Dial Int 2004; 24: 481–6.

Daschner M. , Gfrörer S. , Zachariou Z. , Mehls O. , Schaefer F. Laparoscopic Tenckhoff catheter implantation in children. Perit Dial Int 2002; 22: 22–6.

Mattioli G. , Castagnetti M. , Verrina E. , Trivelli A. , Torre M. , Jasonni V. Laparoscopic-assisted peritoneal dialysis catheter implantation in pediatric patients. Urology 2007; 69: 1185–9.

Copeland D.R. , Blaszak R.T. , Tolleson J.S. , Saad D.F. , Jackson R.J. , Smith S.D. Laparoscopic Tenckhoff catheter placement in children using a securing suture in the pelvis: comparison to the open approach. J Pediatr Surg 2008; 43: 2256–9.

Twardowski Z. , Nichols W. Peritoneal dialysis access and exit site care including surgical aspects. In: Gokal R. , Khanna R. , Krediet R. , Nolph K.D. , eds. Peritoneal Dialysis. Dordrecht, Netherlands: Kluwer Academic Publishers; 2000: 307–61.

Sojo E.T. , Grosman M.D. , Monteverde M.L. , Bailez M.M. , Delgado N. Fibrin glue is useful in preventing early dialysate leakage in children on chronic peritoneal dialysis. Perit Dial Int 2004; 24: 186–90.

Sardegna K.M. , Beck A.M. , Strife C.F. Evaluation of peri-operative antibiotics at the time of dialysis catheter placement. Pediatr Nephrol 1998; 12: 149–52.

Strippoli G.F. , Tong A. , Johnson D. , Schena F.P. , Craig J.C. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 2004; 44: 591–603.

Wikdahl A.M. , Engman U. , Stegmayr B.G. , Sörenssen J.G. One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion. Nephrol Dial Transplant 1997; 12: 157–60.

Lye W.C. , Lee E.J. , Tan C.C. Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 1992; 26: 177–80.

Bennett-Jones D.N. , Martin J. , Barratt A.J. , Duffy T.J. , Naish P.F. , Aber G.M. Prophylactic gentamicin in the prevention of early exit-site infections and peritonitis in CAPD. Adv Perit Dial 1998; 4: 147–50.

Gadallah M.F. , Ramdeen G. , Mignone J. , Patel D. , Mitchell L. , Tatro S. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kidney Dis 2000; 36: 1014–19.

Berns J. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial 2003; 16: 30–7.

Atta M.G. , Eustace J.A. , Song X. , Perl T.M. , Scheel P.J. Jr. Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients. Kidney Int 2001; 59: 718–24.

von Baum H. , Schehl J. , Geiss H.K. , Schaefer F. Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Mid-European Pediatric Peritoneal Dialysis Study Group. Clin Infect Dis 1999; 29: 912–16.

Zelenitsky S. , Barns L. , Findlay I. , Alfa M. , Ariano R. , Fine A. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36: 1009–13.

Troidle L. , Kliger A.S. , Gorban-Brennan N. , Fikrig M. , Golden M. , Finkelstein F.O. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney Int 1996; 50: 1368–72.

Troidle L. , Kliger A.S. , Goldie S.J. , Gorban-Brennan N. , Brown E. , Fikrig M. Continuous peritoneal dialysis– associated peritonitis of nosocomial origin. Perit Dial Int 1996; 16: 505–10.

Berns J.S. , Tokars J.I. Preventing bacterial infections and antimicrobial resistance in dialysis patients. Am J Kidney Dis 2002; 40: 886–98.

Piraino B. , Bailie G.R. , Bernardini J. , Boeschoten E. , Gupta A. , Holmes C. Peritoneal dialysis–related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107–31.

Flanigan M. , Gokal R. Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments. Perit Dial Int 2005; 25: 132–9.

Dombros N. , Dratwa M. , Feriani M. , Gokal R. , Heimbürger O. , Krediet R. European best practice guidelines for peritoneal dialysis. 3. Peritoneal access. Nephrol Dial Transplant 2005; 20(Suppl 9): ix8–12.

Prowant B.F. , Twardowski Z.J. Recommendations for exit care. Perit Dial Int 1996; 16(Suppl 3): S94–9.

Twardowski Z.J. , Prowant B.F. Exit-site healing post catheter implantation. Perit Dial Int 1996; 16(Suppl 3): S51–70.

Prowant B.F. , Warady B.A. , Nolph K.D. Peritoneal dialysis catheter exit-site care: results of an international survey. Perit Dial Int 1993; 13: 149–54.

Twardowski Z.J. , Prowant B.F. Current approaches to exit-site infections in patients on peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 1284–95.

Luzar M.A. , Brown C.B. , Balf D. , Hill L. , Issad B. , Monnier B. Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis. Perit Dial Int 1990; 10: 25–9.

Jones L.L. , Tweedy L. , Warady B.A. The impact of exit-site care and catheter design on the incidence of catheter-related infections. Adv Perit Dial 1995; 11: 302–5.

Hoshii S. , Wada N. , Honda M. on behalf of the Japanese Study Group of Pediatric Peritoneal Dialysis. A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD. Pediatr Nephrol 2006; 21: 828–34.

Wadhwa N.K. , Reddy G.H. Exit-site care in peritoneal dialysis. Contrib Nephrol 2007; 154: 117–24.

Mendoza-Guevara L. , Castro-Vazquez F. , Aguilar-Kitsu A. , Morales-Nava A. , Rodriguez-Leyva F. , Sanchez-Barbosa J.L. Amuchina 10% solution, safe antiseptic for preventing infections of exit-site of Tenckhoff catheters, in the pediatric population of a dialysis program. Contrib Nephrol 2007; 154: 139–44.

Chua A.N. , Goldstein S.L. , Bell D. , Brewer E.D. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin J Am Soc Nephrol 2009; 4: 1939–43.

Piraino B. , Bernardini J. , Bender F.H. An analysis of methods to prevent peritoneal dialysis catheter infections. Perit Dial Int 2008; 28: 437–43.

Chu K.H. , Choy W.Y. , Cheung C.C. , Fung K.S. , Tang H.L. , Lee W. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter–related infections. Perit Dial Int 2008; 28: 505–8.

Bernardini J. , Bender F. , Florio T. , Sloand J. , Palmmontalbano L. , Fried L. Randomized, double-blind trial of antibiotic exit-site cream for prevention of exit-site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16: 539–45.

Johnson D.W. , Clark C. , Isbel N.M. , Hawley C.M. , Beller E. , Cass A. The Honeypot Study protocol: a randomized controlled trial of exit-site application of Medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int 2009; 29: 303–9.

Jassal S.V. , Lok C.E. on behalf of the MP3 Study Group. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients. Perit Dial Int 2008; 28: 67–72.

Piraino B. Staphylococcus aureus infections in dialysis patients. Focus on prevention. ASAIO J 2000; 46: S13–17.

Blowey D.L. , Warady B.A. , McFarland K.S. The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients. Adv Perit Dial 1994; 10: 297–9.

Kingwatanakul P. , Warady B.A. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis. Adv Perit Dial 1997; 13: 281–4.

Gupta B. , Bernardini J. , Piraino B. Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 1996; 28: 415–19.

Swartz R. , Messana J. , Starmann B. , Weber M. , Reynolds J. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 1991; 2: 1085–91.

Turner K. , Uttley L. , Scrimgeour A. , McKewan A. , Gokal R. Natural history of Staphylococcus aureus nasal carriage and its relationship to exit-site infection. Perit Dial Int 1998; 18: 271–3.

Amato D. , de Jesús Ventura M. , Miranda G. , Leaños B. , Alcñntara G. , Hurtado M.E. Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: colonization with identical strains at exit site, nose, and hands. Am J Kidney Dis 2001; 37: 43–8.

Herwaldt L.A. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients. J Hosp Infect 1998; 40(Suppl B): S13–23.

Zimmerman S.W. , Ahrens E. , Johnson C.A. , Craig W. , Leggett J. , O'Brien M. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis–related infections. Am J Kidney Dis 1991; 18: 225–31.

Pérez-Fontñn M. , García-Falcón T. , Rosales M. , Rodríguez– Carmona A. , Adeva M. , Rodríguez-Lozano I. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results. Am J Kidney Dis 1993; 22: 708–12.

Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol 1996; 7: 2403–8.

Thodis E. , Bhaskaran S. , Pasadakis P. , Bargman J.M. , Vas S.I. , Oreopoulos D.G. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit-site. Perit Dial Int 1998; 18: 261–70.

Casey M. , Taylor J. , Clinard P. , Graham A. , Mauck V. , Spain-hour L. Application of the mupirocin cream at the catheter exit-site reduces exit-site infections and peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20: 566–7.

Bernardini J. , Piraino B. , Holley J. , Johnston J.R. , Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit-site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695–700.

Davey P. , Craig A.M. , Hau C. , Malek M. Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized, placebo controlled trial. J Antimicrob Chemother 1999; 43: 105–12.

Wong S.S. , Chu K.H. , Cheuk A. , Tsang W.K. , Fung S.K. , Chan H.W. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit-site. Perit Dial Int 2003; 23(Suppl 2): S153–8.

Araki Y. , Hataya H. , Ikeda M. , Ishikura K. , Honda M. Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis. Perit Dial Int 2003; 23: 267–9.

Piraino B. , Bernardini J. , Florio T. , Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 2003; 23: 456–9.

Ritzau J. , Hoffman R.M. , Tzamaloukas A.H. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis. Perit Dial Int 2001; 21: 471–9.

Tacconelli E. , Carmeli Y. , Aizer A. , Ferreira G. , Foreman M.G. , D'Agata E.M. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37: 1629–38.

Crabtree J.H. , Hadnott L.L. , Burchette R.J. , Siddiqi R.A. Outcome and clinical implications of a surveillance and treat program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Adv Perit Dial 2000; 16: 271–5.

Laupland K.B. , Conly J.M. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 2003; 37: 933–8.

Piraino B. New insights on preventing and managing peritonitis. Pediatr Nephrol 2004; 19: 125–7.

Annigeri R. , Conly J. , Vas S. , Dedier H. , Prakashan K.P. , Bargman J.M. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21: 554–9.

Pérez-Fontñn M. , Rosales M. , Rodríguez-Carmona A. , Falcón T.G. , Valdés F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002; 39: 337–41.

Lobbedez T. , Gardam M. , Dedier H. , Burdzy D. , Chu M. , Izatt S. Routine use of mupirocin at the peritoneal catheter exit-site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 2004; 19: 3140–3.

Mahaldar A. , Weisz M. , Kathuria P. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis. Adv Perit Dial 2009; 25: 56–9.

Lok C.E. , Stanley K.E. , Hux J.E. , Richardson R. , Tobe S.W. , Conly J. Hemodialysis infection prevention with Polysporin ointment. J Am Soc Nephrol 2003; 14: 169–79.

McQuillan R.F. , Chiu E. , Nessim S. , Lok C.E. , Roscoe J.M. , Tam P. A randomized controlled trial comparing mupirocin and Polysporin Triple ointments in peritoneal dialysis patients: the MP3 Study. Clin J Am Soc Nephrol 2012; 7: 297–303.

Cooper R.A. , Halas E. , Molan P.C. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J Burn Care Rehabil 2002; 23: 366–70.

Cooper R.A. , Molan P.C. , Harding K.G. The sensitivity to honey of gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 2002; 93: 857–63.

Johnson D.W. , van Eps C. , Mudge D.W. , Wiggins K.J. , Armstrong K. , Hawley C.M. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 2005; 16: 1456–62.

Daly C.D. , Campbell M.K. , MacLeod A.M. , Cody D.J. , Vale L.D. , Grant A.M. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001; 16: 341–7.

Maiorca R. , Cantaluppi A. , Cancarini G.C. , Scalamogna A. , Broccoli R. , Graziani G. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983; 2: 642–4.

Rottembourg J. , Brouard R. , Issad B. , Allouache M. , Jacobs C. Prospective randomized study about Y connectors in CAPD patients. Adv Perit Dial 1987; 3: 107–13.

Lindholm T. , Simonsen O. , Krutzen L. , van Leusen R. Evaluation of a new take-off system: a prospective randomized multicenter study. Adv Perit Dial 1988; 4: 262–5.

Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Canadian CAPD Clinical Trials Group. Perit Dial Int 1989; 9: 159–63.

Owen J.E. , Walker R.G. , Lemon J. , Brett L. , Mitrou D. , Becker G.J. Randomized study of peritonitis with conventional versus O-set techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 216–20.

Li P.K. , Chan T.H. , So W.Y. , Wang A.Y. , Leung C.B. , Lai K.N. Comparisons of Y-set disconnect system (Ultraset) versus conventional spike system in uremic patients on CAPD: outcome and cost analysis. Perit Dial Int 1996; 16(Suppl 1): S368–70.

Monteón F. , Correa-Rotter R. , Paniagua R. , Amato D. , Hurtado M.E. , Medina J.L. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group. Kidney Int 1998; 54: 2123–8.

Cheng I.K. , Chan C.Y. , Cheng S.W. , Poon J.F. , Ji Y.L. , Lo W.K. A randomized prospective study of the cost-effectiveness of the conventional spike, O-set and UVXD techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14: 255–60.

Kiernan L. , Kliger A. , Gorban-Brennan N. , Juergensen P. , Tesin D. , Vonesh E. Comparison of continuous ambulatory peritoneal dialysis–related infections with different “Y-tubing” exchange systems. J Am Soc Nephrol 1995; 5: 1835–8.

Ong L.M. , Lim T.O. , Hooi L.S. , Morad Z. , Tan P.C. , Wong H.S. A randomized, multicenter, open-label trial to establish therapeutic equivalence between the Carex and Ultra disconnect systems in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2003; 23(Suppl 2): S139–43.

Wong H.S. , Ong L.M. , Lim T.O. , Hooi L.S. , Morad Z. , Ghazalli R. A randomized multicenter, open-label trial to determine peritonitis rate, product defect, and technique survival between ANDY-Disc and UltraBag in patients on CAPD. Am J Kidney Dis 2006; 48: 464–72.

Smith C.A. Reduced incidence of peritonitis by utilizing “flush before fill” in APD. Adv Perit Dial 1997; 13: 224–6.

Warady B.A. , Ellis E.N. , Fivush B.A. , Lum G.M. , Alexander S.R. , Brewer E.D. “Flush before fill” in children receiving automated peritoneal dialysis. Perit Dial Int 2003; 23: 493–8.

Bazzato G. , Landini S. , Fracasso A. , Morachiello P. , Righetto F. , Scanferla F. Why the double-bag system still remains the best technique for peritoneal fluid exchange in continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2): S152–5.

Cox S.D. , Steddon S. , Mallinder S. , Fan S.L. , Punzalan S. Re-training and switching of PD system to reduce recurrent gram-positive PD peritonitis. J Ren Care 2006; 32: 198–201.

Miles R. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76: 622–8.

Wang A.Y. , Yu A.W. , Li P.K. , Lam P.K. , Leung C.B. , Lai K.N. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36: 1183–92.

Raaijmakers R. , Schröder C. , Monnens L. , Cornelissen E. , Warris A. Fungal peritonitis in children on peritoneal dialysis. Pediatr Nephrol 2007; 22: 288–93.

Davenport A. , Wellsted D. on behalf of the Pan Thames Renal Audit Peritoneal Dialysis Group. Does antifungal prophylaxis with daily oral fluconazole reduce the risk of fungal peritonitis in peritoneal dialysis patients? The Pan Thames Renal Audit. Blood Purif 2011; 32: 181–5.

Michel C. , Courdavault L. , al Khayat R. , Viron B. , Roux P. , Mignon F. Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol 1994; 14: 113–20.

Goldie S.J. , Kiernan-Tridle L. , Torres C. , Gorban-Brennan N. , Dunne D. , Kliger A.S. Fungal peritonitis in a large peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28: 86–91.

Bren A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1998; 17: 839–43.

Warady B.A. , Bashir M. , Donaldson L.A. Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int 2000; 58: 384–9.

Prasad K.N. , Prasad N. , Gupta A. , Sharma R.K. , Verma A.K. , Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 2004; 48: 96–101.

Lo W.K. , Chan C.Y. , Cheng S.W. , Poon J.F. , Chan D.T. , Cheng I.K. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 549–52.

Zñruba K. , Peters J. , Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years experience. Am J Kidney Dis 1991; 17: 43–6.

Robitaille P. , Mérouani A. , Clermónt M.J. , Hébert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 1995; 15: 77–9.

Wadhwa N.K. , Suh H. , Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial 1996; 12: 189–91.

Thodis E. , Vas S.I. , Bargman J.M. , Singhal M. , Chu M. , Oreopoulos D.G. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18: 583–9.

Williams P.F. , Moncrieff N. , Marriott J. No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20: 352–3.

Moreiras-Plaza M. , Vello-Romñn A. , Sampróm-Rodríguez M. , Feijóo-Piñeiro D. Ten years without fungal peritonitis: a single center's experience. Perit Dial Int 2007; 27: 460–3.

Restrepo C. , Chacon J. , Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int 2010; 30: 619–25.

Lye W.C. Nystatin prophylaxis for fungal peritonitis: to be or not to be? Perit Dial Int 2007; 27: 511–13.

Wong P.N. , Lo K.Y. , Tong G.M. , Chan S.F. , Lo M.W. , Mak S.K. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 2007; 27: 531–6.

Piraino B. Peritoneal infections. Adv Ren Replace Ther 2000; 7: 280–8.

Prasad N. , Gupta A. Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2005; 25: 207–22.

Wilson W. , Taubert K.A. , Gewitz M. , Lockhart P.B. , Baddour L.M. , Levison M. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 1736–54.

Dajani A.S. , Taubert K.A. , Wilson W. , Bolger A.F. , Bayer A. , Ferrieri P. Prevention of bacterial endocarditis: recommendations by the American Heart Association. J Am Dent Assoc 1997; 128: 1142–51.

Banerjee S. , Shen B. , Baron T.H. , Nelson D.B. , Anderson M.A. , Cash B.D. on behalf of the ASGE Standards of Practice Committee. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008; 67: 791–8.

Jafri N.S. , Mahid S.S. , Minor K.S. , Idstein S.R. , Hornung C.A. , Galandiuk S. Meta-analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy. Aliment Pharmacol Ther 2007; 25: 647–56.

Ramage I.J. , Geary D.F. , Harvey E. , Secker D.J. , Balfe J.A. , Balfe J.W. Efficacy of gastrostomy feeding in infants and older children receiving chronic peritoneal dialysis. 1999; 19: 231–6.

Murugasu B. , Conley S.B. , Lemire J.M. , Portman R.J. Fungal peritonitis in children treated with peritoneal dialysis and gastrostomy feeding. Pediatr Nephrol 1991; 5: 620–1.

Ledermann S.E. , Spitz L. , Moloney J. , Rees L. , Trompeter R.S. Gastrostomy feeding in infants and children on peritoneal dialysis. Pediatr Nephrol 2002; 17: 246–50.

von Schnakenburg C. , Feneberg R. , Plank C. , Zimmering M. , Arbeiter K. , Bald M. Percutaneous endoscopic gastrostomy in children on peritoneal dialysis. Perit Dial Int 2006; 26: 69–77.

Rees L. , Brandt M.L. Tube feeding in children with chronic kidney disease: technical and practical issues. Pediatr Nephrol 2010; 25: 699–704.

Flanigan M.J. , Freeman R.M. , Lim V.S. Cellular response to peritonitis among peritoneal dialysis patients. Am J Kidney Dis 1985; 6: 420–4.

Gould I.M. , Casewell M.W. The laboratory diagnosis of peritonitis during continuous ambulatory peritoneal dialysis. J Hosp Infect 1986; 7: 155–60.

Betjes M.G. , Tuk C.W. , Visser C.E. , Zemel D. , Krediet R.T. , Arisz L. Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. Nephrol Dial Transplant 1994; 9: 684–92.

Koopmans J.G. , Boeschoten E.W. , Pannekeet M.M. , Betjes M.G. , Zemel D. , Kuijper E.J. Impaired initial cell reaction in CAPD-related peritonitis. Perit Dial Int 1996; 16(Suppl 1): S362–7.

Rocklin M.A. , Teitelbaum I. Noninfectious causes of cloudy peritoneal dialysate. Semin Dial 2001; 14: 37–40.

Chadha V. , Schaefer F.S. , Warady B.A. Dialysis-associated peritonitis in children. Pediatr Nephrol 2010; 25: 425–40.

Schaefer F. , Klaus G. , Müller-Wiefel D.E. , Mehls O. Intermittent versus continuous intraperitoneal glycopeptide/ ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). J Am Soc Nephrol 1999; 10: 136–45.

Akman S. , Uygun V. , Guven A.G. Value of the urine strip test in the early diagnosis of bacterial peritonitis. Pediatr Int 2005; 47: 523–7.

Park S.J. , Lee J.Y. , Tak W.T. , Lee J.H. Using reagent strips for rapid diagnosis of peritonitis in peritoneal dialysis patients. Adv Perit Dial 2005; 21: 69–71.

Quinlan C. , Cantwell M. , Rees L. Eosinophilic peritonitis in children on chronic peritoneal dialysis. Pediatr Nephrol 2010; 25: 517–22.

von Graevenitz A. , Amsterdam D. Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis. Clin Microbiol Rev 1992; 5: 36–48.

Lye W.C. , Wong P.L. , Leong S.O. , Lee E.J. Isolation of organisms in CAPD peritonitis: a comparison of two techniques. Adv Perit Dial 1994; 10: 166–8.

Sewell D.L. , Golper T.A. , Hulman P.B. , Thomas C.M. , West L.M. , Kubey W.Y. Comparison of large volume culture to other methods for isolation of microorganisms from dialysate. Perit Dial Int 1990; 10: 49–52.

Blondeau J.M. , Pylypchuk G.B. , Kappel J.E. , Pilkey B. , Lawler C. Comparison of bedside- and laboratory-inoculated Bactec high- and low-volume resin bottles for the recovery of microorganisms causing peritonitis in CAPD patients. Diagn Microbiol Infect Dis 1998; 31: 281–7.

Chow K.M. , Chow V.C. , Szeto C.C. , Law M.C. , Leung C.B. , Li P.K. Continuous ambulatory peritoneal dialysis peritonitis: broth inoculation culture versus water lysis method. Nephron Clin Pract 2007; 105: c121–5.

Azap O.K. , Timurkaynak F. , Sezer S. , Cağir U. , Yapar G. , Arslan H. Value of automatized blood culture systems in the diagnosis of continuous ambulatory peritoneal dialysis peritonitis. Transplant Proc 2006; 38: 411–12.

Yoo T.H. , Chang K.H. , Ryu D.R. , Kim J.S. , Choi H.Y. , Park H.C. Usefulness of 23S rRNA amplification by PCR in the detection of bacteria in CAPD peritonitis. Am J Nephrol 2006; 26: 115–20.

Johnson G. , Wilks M. , Warwick S. , Millar M.R. , Fan S.L. Comparative study of diagnosis of PD peritonitis by quantitative polymerase chain reaction for bacterial DNA vs culture methods. J Nephrol 2006; 19: 45–9.

Cervelli M.J. , ed. The Renal Drug Reference Guide. Adelaide, Australia: Kidney Health Australia; 2007.

Taketomo C.K. , Hodding J.H. , Kraus D.M. Pediatric Dosage Handbook: Including Neonatal Dosing, Drug Administration, and Extemporaneous Preparations. 17th ed. Hudson, OH: Lexi-Comp; 2010.

Manley H.J. , Bailie G.R. Treatment of peritonitis in APD: pharmacokinetic principles. Semin Dial 2002; 15: 418–21.

Manley H.J. , Bridwell D.L. , Elwell R.J. , Bailie G.R. Influence of peritoneal dialysate flow rate on the pharmacokinetics of cefazolin. Perit Dial Int 2003; 23: 469–74.

Cheng I.K. , Fang G.X. , Chau P.Y. , Chan T.M. , Tong K.L. , Wong A.K. A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD. Perit Dial Int 1998; 18: 371–5.

Sisterhen L.L. , Stowe C.D. , Farrar H.C. , Blaszak C.K. , Blaszak R.T. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis. Am J Kidney Dis 2006; 47: 503–8.

Blowey D.L. , Warady B.A. , Abdel-Rahman S. , Frye R.F. , Manley H.J. Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis. Perit Dial Int 2007; 27: 79–85.

De Broe M.E. , Giuliano R.A. , Verpooten G.A. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity. Am J Med 1986; 80: 115–18.

Golper T. Intermittent versus continuous antibiotics for PD-related peritonitis. Perit Dial Int 1997; 17: 11–12.

Bailie G.R. , Haqqie S.S. , Eisele G. , Gorman T. , Low C.L. Effectiveness of once-weekly vancomycin and once-daily gentamicin, intraperitoneally, for CAPD peritonitis. Perit Dial Int 1995; 15: 269–71.

Vas S. , Bargman J. , Oreopoulos D. Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int 1997; 17: 91–4.

Lai M.N. , Kao M.T. , Chen C.C. , Cheung S.Y. , Chung W.K. Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis. Perit Dial Int 1997; 17: 87–9.

Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; (103): S55–62.

Wong K.M. , Chan Y.H. , Cheung C.Y. , Chak W.L. , Choi K.S. , Leung S.H. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis. Am J Kidney Dis 2001; 38: 127–31.

Li P.K. , Ip M. , Law M.C. , Szeto C.C. , Leung C.B. , Wong T.Y. Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis. Perit Dial Int 2000; 20: 232–4.

Yahav D. , Paul M. , Fraser A. , Sarid N. , Leibovici L. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis 2009; 7: 338–48.

Fisher B.T. , Aplenc R. , Localio R. , Leckerman K.H. , Zaoutis T.E. Cefepime and mortality in pediatric acute myelogenous leukemia: a retrospective cohort study. Pediatr Infect Dis J 2009; 28: 971–5.

Kim P.W. , Wu Y.T. , Cooper C. , Rochester G. , Valappil T. , Wang Y. Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis 2010; 51: 381–9.

Sonck J. , Laureys G. , Verbeelen D. The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant 2008; 23: 966–70.

Yuen S.K. , Yong S.P. , Tsui H.S. Neurotoxicity secondary to intraperitoneally administered cefepime: report of two cases. Hong Kong J Nephrol 2004; 6: 106–8.

Khairullah Q. , Provenzano R. , Tayeb J. , Ahmad A. , Balakrishnan R. , Morrison L. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients. Perit Dial Int 2002; 22: 339–44.

Lui S.L. , Cheng S.W. , Ng F. , Ng S.Y. , Wan K.M. , Yip T. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 2005; 68: 2375–80.

Shemin D. , Bostom A.G. , Lambert C. , Hill C. , Kitsen J. , Kliger A.S. Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int 2000; 20: 439–44.

Govindarajulu S. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. , Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int 2010; 30: 311–19.

Szeto C.C. , Chow K.M. , Kwan B.C. , Law M.C. , Chung K.Y. , Yu S. , Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin J Am Soc Nephrol 2007; 2: 245–51.

Huang S.S. , Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36: 281–5.

Szeto C.C. , Kwan B.C. , Chow K.M. , Lau M.F. , Law M.C. , Chung K.Y. Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol 2008; 3: 91–9.

Perl T.M. The threat of vancomycin resistance. Am J Med 1999; 106: 26S–7S.

Servais A. , Mercadal L. , Brossier F. , Venditto M. , Issad B. , Isnard-Bagnis C. Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department. Clin J Am Soc Nephrol 2009; 4: 1559–64.

Barbosa D. , Lima L. , Silbert S. , Sader H. , Cendoroglo M. , Draibe S. Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis. Am J Kidney Dis 2004; 44: 337–43.

Edey M. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant 2010; 25: 1272–8.

Sutherland S.M. , Alexander S.R. , Feneberg R. , Schaefer F. , Warady B.A. on behalf of the International Pediatric Peritonitis Registry (IPPR). Enterococcal peritonitis in children receiving chronic peritoneal dialysis. Nephrol Dial Transplant 2010; 25: 4048–54.

Vinh D.C. , Rubinstein E. Linezolid: a review of safety and tolerability. J Infect 2009; 59(Suppl 1): S59–74.

Goffin E. , Herbiet L. , Pouthier D. , Pochet J.M. , Lafontaine J.J. , Christophe J.L. Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis– associated peritonitis. Perit Dial Int 2004; 24: 433–9.

Lima R.C. , Barreira A. , Cardoso F.L. , Lima M.H. , Leite M. Jr. Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up. Perit Dial Int 2007; 27: 56–60.

Lye W.C. , Lee E.J. , van der Straaten J. Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis. Perit Dial Int 1993; 13(Suppl 2): S348–50.

Yeung S.M. , Walker S.E. , Tailor S.A. , Awdishu L. , Tobe S. , Yassa T. Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis. Perit Dial Int 2004; 24: 447–53.

Fontñn M.P. , Cambre H.D. , Rodríguez-Carmona A. , Muñiz A.L. , Falcón T.G. Treatment of peritoneal dialysis–related peritonitis with ciprofloxacin monotherapy: clinical outcomes and bacterial susceptibility over two decades. Perit Dial Int 2009; 29: 310–18.

Carmeli Y. , Eliopoulos G.M. , Samore M.H. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002; 8: 802–7.

Oprea S.F. , Zaidi N. , Donabedian S.M. , Balasubramaniam M. , Hershberger E. , Zervos M.J. Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis. J Antimicrob Chemother 2004; 53: 626–30.

Grady R. Safety profile of quinolone antibiotics in the pediatric population. Pediatr Infect Dis J 2003; 22: 1128–32.

Noel G.J. , Bradley J.S. , Kauffman R.E. , Duffy C.M. , Gerbino P.G. , Arguedas A. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J 2007; 26: 879–91.

Sansone J.M. , Wilsman N.J. , Leiferman E.M. , Conway J. , Hutson P. , Noonan K.J. The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model. J Pediatr Orthop 2009; 29: 189–95.

Adefurin A. , Sammons H. , Jacqz-Aigrain E. , Choonara I. Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child 2011; 96: 874–80.

Chyský V. , Kapila K. , Hullmann R. , Arcieri G. , Schacht P. , Echols R. Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection 1991; 19: 289–96.

Pradhan K.M. , Arora N.K. , Jena A. , Susheela A.K. , Bhan M.K. Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growth. Acta Paediatr 1995; 84: 855–60.

Kobayashi K. , Nakamoto H. , Okada S. , Hoshitani K. , Uchida K. , Arima H. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 2006; 22: 65–8.

Dratwa M. , Glupczynski Y. , Lameire N. , Matthys D. , Verschraegen G. , Vaneechoutte M. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis 1991; 13(Suppl 7): S645–7.

Shemin D. , Maaz D. , St Pierre D. , Kahn S.I. , Chazan J.A. Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 1999; 34: 14–20.

Warady B.A. , Reed L. , Murphy G. , Kastetter S. , Karlsen E. , Alon U. Aminoglycoside ototoxicity in pediatric patients receiving long-term peritoneal dialysis. Pediatr Nephrol 1993; 7: 178–81.

Szeto C.C. , Chow K.M. , Leung C.B. , Wong T.Y. , Wu A.K. , Wang A.Y. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases. Kidney Int 2001; 59: 2309–15.

Burgess D.S. , Nathisuwan S. Cefepime, piperacillin/ tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 2002; 44: 35–41.

Ariffin H. , Navaratnam P. , Mohamed M. , Arasu A. , Abdullah W.A. , Lee C.L. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia. Int J Infect Dis 2000; 4: 21–5.

Kim Y.K. , Pai H. , Lee H.J. , Park S.E. , Choi E.H. , Kim J. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002; 46: 1481–91.

Asensio A. , Oliver A. , Gonzñlez-Diego P. , Baquero F. , Pérez-Díaz J.C. , Ros P. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000; 30: 55–60.

Rice L.B. , Eckstein E.C. , DeVente J. , Shlaes D.M. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 118–24.

Yip T. , Tse K.C. , Lam M.F. , Tang S. , Li F.K. , Choy B.Y. Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients. Perit Dial Int 2006; 26: 191–7.

Zanetti G. , Bally F. , Greub G. , Garbino J. , Kinge T. , Lew D. on behalf of the Cefepime Study Group. Cefepime versus imipenem–cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. Antimicrob Agents Chemother 2003; 47: 3442–7.

Blowey D.L. , Garg U.C. , Kearns G.L. , Warady B.A. Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis. Adv Perit Dial 1998; 14: 247–50.

Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int 2009; 29(Suppl 2): S161–5.

McNeeley D.J. , Vas S.I. , Dombros N. , Oreopoulos D.G. Fusarium peritonitis: an uncommon complication of CAPD. Perit Dial Bull 1981; 1: 94–6.

Chang T.I. , Kim H.W. , Park J.T. , Lee D.H. , Lee J.H. , Yoo T.H. Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center. Perit Dial Int 2011; 31: 60–6.

Pappas P.G. , Kauffman C.A. , Andes D. , Benjamin D.K. Jr. , Calandra T.F. , Edwards J.E. Jr. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503–35.

Kavanagh D. , Prescott G.J. , Mactier R.A. Peritoneal dialysis– associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004; 19: 2584–91.

Spare M.K. , Tebbs S.E. , Lang S. , Lambert P.A. , Worthington T. , Lipkin G.W. Genotypic and phenotypic properties of coagulase-negative staphylococci causing dialysis catheter-related sepsis. J Hosp Infect 2003; 54: 272–8.

Pickering S.J. , Bowley J.A. , Fleming S.J. , Oppenheim B.A. , Ralston A.J. , Sissons P. Urokinase for recurrent CAPD peritonitis. Lancet 1987; 1: 1258–9.

Williams A.J. , Boletis I. , Johnson B.F. , Raftery A.T. , Cohen G.L. , Moorhead P.J. Tenckhoff catheter replacement or intraperitoneal urokinase: a randomized trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis. Perit Dial Int 1989; 9: 65–7.

Klaus G. , Schäfer F. , Querfeld U. , Soergel M. , Wolf S. , Mehls O. Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis. Adv Perit Dial 1992; 8: 302–5.

Innes A. , Burden R.P. , Finch R.G. , Morgan A.G. Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial. Nephrol Dial Transplant 1994; 9: 797–9.

Worland M.A. , Radabaugh R.S. , Mueller B.A. Intraperitoneal thrombolytic therapy for peritoneal dialysis-associated peritonitis. Ann Pharmacother 1998; 32: 1216–20.

Gadallah M.F. , Tamayo A. , Sandborn M. , Ramdeen G. , Moles K. Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients. Adv Perit Dial 2000; 16: 233–6.

Tong M.K. , Leung K.T. , Siu Y.P. , Lee K.F. , Lee H.K. , Yung C.Y. Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis. J Nephrol 2005; 18: 204–8.

Wiggins K.J. , Craig J.C. , Johnson D.W. , Strippoli G.F. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev 2008;: CD005284.

Duch J.M. , Yee J. Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. Am J Kidney Dis 2001; 37: 149–53.

Zorzanello M.M. , Fleming W.J. , Prowant B.E. Use of tissue plasminogen activator in peritoneal dialysis catheters: a literature review and one center's experience. Nephrol Nurs J 2004; 31: 534–7.

Margetts P. Heparin and the peritoneal membrane. Perit Dial Int 2009; 29: 16–19.

de Boer A.W. , Levi M. , Reddingius R.E. , Willems J.L. , van den Bosch S. , Schröder C.H. Intraperitoneal hypercoagulation and hypofibrinolysis is present in childhood peritonitis. Pediatr Nephrol 1999; 13: 284–7.

Nadig C. , Binswanger U. , von Felten A. Is heparin therapy necessary in CAPD peritonitis? Perit Dial Int 1997; 17: 493–6.

Lamperi S. , Carozzi S. Immunological defenses in CAPD. Blood Purif 1989; 7: 126–43.

Keane W.F. , Comty C.M. , Verbrugh H.A. , Peterson P.K. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25: 539–43.

Lamperi S. , Carozzi S. Defective opsonic activity of peritoneal effluent during continuous ambulatory peritoneal dialysis patients: importance and prevention. Perit Dial Bull 1986; 6: 87–92.

McGregor S.J. , Brock J.H. , Briggs J.D. , Junor B.J. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis. Nephrol Dial Transplant 1987; 2: 551–6.

Poyrazoğlu H.M. , Düşünsel R. , Patiroğlu T. , Gündüz Z. , Utaş C. , Güneş T. . Humoral immunity and frequency of peritonitis in chronic peritoneal dialysis patients. Pediatr Nephrol 2002; 17: 85–90.

Krediet R.T. , Koomen G.C. , Vlug A. , Struijk D.G. , Buis B. , van Olden R.W. IgG subclasses in CAPD patients. Perit Dial Int 1996; 16: 288–94.

Akman S. , Güven A.G. , Ince S. , Yeğin O. IgG and IgG subclasses deficiency in children undergoing continuous ambulatory peritoneal dialysis and its provocative factors. Pediatr Int 2002; 44: 273–6.

Keane W. , Bergeron B. , Pence T. , Peterson P. Challenges for continuous ambulatory peritoneal dialysis. In: Davison A.M. , ed. Nephrology: Proceedings of the Xth International Congress of Nephrology. London, UK: Balliere Tindall; 1987: 1255–67.

Lamperi S. , Carozzi S. Peritonitis prevention in CAPD by intraperitoneal IgG. Contrib Nephrol 1989; 70: 325–9.

Dursun B. , Tuncer M. , Felek R. , Ersoy F.F. Benefits of low dose immunoglobulin in the treatment of refractory CAPD peritonitis and longevity of technical survival on CAPD. Int Urol Nephrol 2005; 37: 565–9.

Coban E. , Ozdogan M. , Tuncer M. , Bozcuk H. , Ersoy F. The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis– related peritonitis. J Nephrol 2004; 17: 427–40.

Akman S. , Güven A.G. , Ince S. , Yegin O. Effect of intraperitoneal immunoglobulin infusion on neutrophil function in CAPD children with and without peritonitis. Adv Perit Dial 1998; 14: 239–42.

Anwar N. , Hutchison A.J. , Manos J. , Uttley L. , Brenchley P. , Gokal R. Peritoneal dialysate IgG/C3 levels do not predict susceptibility to peritonitis. Perit Dial Int 1996; 16: 154–7.

Bouts A.H. , Davin J.C. , Krediet R.T. , van der Weel M.B. , Schröder C.H. , Monnens L. Immunoglobulins in chronic renal failure of childhood: effects of dialysis modalities. Kidney Int 2000; 58: 629–37.

Neu A.M. , Warady B.A. , Lederman H.M. , Furth S.L. , Fivush B.A. Hypogammaglobulinemia in infants and young children maintained on peritoneal dialysis. Pediatric Dialysis Study Consortium. Perit Dial Int 1998; 18: 440–3.

Piraino B. Peritoneal dialysis catheter replacement: “save the patient and not the catheter.” Semin Dial 2003; 16: 72–5.

Choi P. , Nemati E. , Banerjee A. , Preston E. , Levy J. , Brown E. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization. Am J Kidney Dis 2004; 43: 103–11.

Szeto C.C. , Chow K.M. , Wong T.Y. , Leung C.B. , Wang A.Y. , Lui S.F. Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal. J Am Soc Nephrol 2002; 13: 1040–5.

Schröder C.H. , Severijnen R.S. , de Jong M.C. , Monnens L.A. Chronic tunnel infections in children: removal and replacement of the continuous ambulatory peritoneal dialysis catheter in a single operation. Perit Dial Int 1993; 13: 198–200.

Lye W.C. , Leong S.O. , van der Straaten J. , Lee E.J. Staphylococcus aureus CAPD-related infections are associated with nasal carriage. Adv Perit Dial 1994; 10: 163–5.

Lui S.L. , Li F.K. , Lo C.Y. , Lo W.K. Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection. Adv Perit Dial 2000; 16: 195–7.

Lui S.L. , Yip T. , Tse K.C. , Lam M.F. , Lai K.N. , Lo W.K. Treatment of refractory Pseudomonas aeruginosa exit-site infection by simultaneous removal and reinsertion of peritoneal dialysis catheter. Perit Dial Int 2005; 25: 560–3.

Bernardini J. , Piraino B. , Sorkin M. Analysis of continuous ambulatory peritoneal dialysis–related Pseudomonas aeruginosa infections. Am J Med 1987; 83: 829–32.

Siva B. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. , Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 2009; 4: 957–64.

Mitra A. , Teitelbaum I. Is it safe to simultaneously remove and replace infected peritoneal dialysis catheters? Review of the literature and suggested guidelines. Adv Perit Dial 2003; 19: 255–9.

Swartz R. , Messana J. , Reynolds J. , Ranjit U. Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections. Kidney Int 1991; 40: 1160–5.

Scalamogna A. , De Vecchi A. , Maccario M. , Castelnovo C. , Ponticelli C. Cuff-shaving procedure. A rescue treatment for exit-site infection unresponsive to medical therapy. Nephrol Dial Transplant 1995; 10: 2325–7.

Swartz R.D. , Messana J.M. Simultaneous catheter removal and replacement in peritoneal dialysis infections: update and current recommendations. Adv Perit Dial 1999; 15: 205–8.

Finkelstein E.S. , Jekel J. , Troidle L. , Gorban-Brennan N. , Finkelstein F.O. , Bia F.J. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002; 39: 1278–86.

Singhal M.K. , Vas S.I. , Oreopoulos D.G. Treatment of peritoneal dialysis catheter–related infections by simultaneous catheter removal and replacement. Is it safe? Perit Dial Int 1998; 18: 565–7.

Majkowski N.L. , Mendley S.R. Simultaneous removal and replacement of infected peritoneal dialysis catheters. Am J Kidney Dis 1997; 29: 706–11.

Goldraich I. , Mariano M. , Rosito N. , Goldraich N. One-step peritoneal catheter replacement in children. Adv Perit Dial 1993; 9: 325–8.

Cancarini G.C. , Manili L. , Brunori G. , Camerini C. , Zubani R. , Colombrita D. Simultaneous catheter replacement-removal during infectious complications in peritoneal dialysis. Adv Perit Dial 1994; 10: 210–13.

Posthuma N. , Borgstein P.J. , Eijsbouts Q. , ter Wee P.M. Simultaneous peritoneal dialysis catheter insertion and removal in catheter-related infections without interruption of peritoneal dialysis. Nephrol Dial Transplant 1998; 13: 700–3.

Vychytil A. , Lilaj T. , Lorenz M. , Hörl W.H. , Haag-Weber M. Ultrasonography of the catheter tunnel in peritoneal dialysis patients: what are the indications? Am J Kidney Dis 1999; 33: 722–7.

Karahan O.I. , Taskapan H. , Yikilmaz A. , Oymak O. , Utas C. Ultrasound evaluation of peritoneal catheter tunnel in catheter related infections in CAPD. Int Urol Nephrol 2005; 37: 363–6.

Stuart S. , Booth T.C. , Cash C.J. , Hameeduddin A. , Goode J.A. , Harvey C. Complications of continuous ambulatory peritoneal dialysis. Radiographics 2009; 29: 441–60.

Vychytil A. , Lorenz M. , Schneider B. , Hörl W.H. , Haag-Weber M. New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography. J Am Soc Nephrol 1998; 9: 290–6.

Kwan T.H. , Tong M.K. , Siu Y.P. , Leung K.T. , Luk S.H. , Cheung Y.K. Ultrasonography in the management of exit site infections in peritoneal dialysis patients. Nephrology (Carlton) 2004; 9: 348–52.

Khanna R. , Twardowski Z.J. Recommendations for treatment of exit-site pathology. Perit Dial Int 1996; 16(Suppl 3): S100–4.

Yoshino A. , Honda M. , Ikeda M. , Tsuchida S. , Hataya H. , Sakazume S. Merit of the cuff-shaving procedure in children with chronic infection. Pediatr Nephrol 2004; 19: 1267–72.

Macchini F. , Testa S. , Valadè A. , Torricelli M. , Leva E. , Ardissino G. Conservative surgical management of catheter infections in children on peritoneal dialysis. Pediatr Surg Int 2009; 25: 703–7.

Brulez H.F. , Verbrugh H.A. First-line defense mechanisms in the peritoneal cavity during peritoneal dialysis. Perit Dial Int 1995; 15(Suppl 7): S24–33.

McGregor S.J. , Brock J.H. , Briggs J.D. , Junor B. Longitudinal study of peritoneal defense mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9: 115–19.

de Fijter C.W. , Verbrugh H.A. , Oe L.P. , Peters E.D. , van der Meulen J. , Donker A.J. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 1992; 42: 947–50.

Lewis S. , Holmes C. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1991; 11: 14–21.

Jörres A. , Topley N. , Witowski J. , Liberek T. , Gahl G.M. Impact of peritoneal dialysis solutions on peritoneal immune defense. Perit Dial Int 1993; 13(Suppl 2): S291–4.

Cameron J.S. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis. Pediatr Nephrol 1995; 9: 647–62.

Posthuma N. , ter Wee P. , Donker A.J. , Dekker H.A. , Oe P.L. , Verbrugh H.A. Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients. Perit Dial Int 1999; 19: 334–42.

Pajek J. , Kveder R. , Bren A. , Gucek A. , Ihan A. , Osredkar J. Short-term effects of a new bicarbonate/lactate– buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Perit Dial Int 2008; 28: 44–52.

Gokal R. , Alexander S. , Ash S. , Chen T.W. , Danielson A. , Holmes C. Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. (Official report from the International Society for Peritoneal Dialysis). Perit Dial Int 1998; 18: 11–33.

Kaplan R.A. , Alon V. , Hellerstein S. , Warady B.A. Unusual causes of peritonitis in three children receiving peritoneal dialysis. Perit Dial Int 1993; 13: 60–3.

Borg D. , Shetty A. , Williams D. , Faber M.D. Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program. Adv Perit Dial 2003; 19: 202–5.

Diaz-Buxo J.A. , Wick G.S. , Pesich A.A. Using CQI techniques for managing infections in PD patients. Nephrol News Issues 1998; 12: 22–4.

Schaefer F. , Kandert M. , Feneberg R. Methodological issues in assessing the incidence of peritoneal dialysis– associated peritonitis in children. Perit Dial Int 2002; 22: 234–8.

Roberts D.M. , Fernando G. , Singer R.F. , Kennedy K.J. , Lawrence M. , Talaulikar G. Antibiotic stability in commercial peritoneal dialysis solutions: influence of formulation, storage and duration. Nephrol Dial Transplant 2011; 26: 3344–9.

Williamson J.C. , Volles D.F. , Lynch P.L. , Rogers P.D. , Haverstick D.M. Stability of cefepime in peritoneal dialysis solution. Ann Pharmacother 1999; 33: 906–9.

de Vin F. , Rutherford P. , Faict D. Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use. Perit Dial Int 2009; 29: 5–15.

Voges M. , Faict D. , Lechien G. , Taminne M. Stability of drug additives in peritoneal dialysis solutions in a new container. Perit Dial Int 2004; 24: 590–5.